Laura M Robinson

US Patent:

20120289931, Nov 15, 2012

Filed:

May 9, 2012

Appl. No.:

13/467570

Inventors:

Laura Jean Robinson - Minneapolis MN, US
Ida Schneck - Minneapollis MN, US

International Classification:

A61M 5/31
G08B 5/22
H05K 7/00
A61M 5/315

US Classification:

604506, 604218, 604191, 340 81, 340 61, 36167901

Abstract:

A medicament delivery system and method of use. A medicament delivery system comprising a medicament, a medicament delivery device, an alerting device, operating instructions, and a carrying case. The medicament can be glucagon for use with Type 1 diabetics. A method where a person assisting a patient in medical distress locates the patient's medicament injection pen by using an alerting device that sends a signal to the pen's carrying case, and where a triggered alarm in the case alerts the assisting person of the pen's whereabouts. A method where a person assisting a patient in medical distress provides a medicament to the patient by pushing an actuator on a medicament injection pen until a diaphragm separating two chambers in the pen breaks allowing medicament and diluting solution to mix, and where the assisting person then injects the mixture into a soft tissue of the patient.

US Patent:

20080235053, Sep 25, 2008

Filed:

Mar 20, 2007

Appl. No.:

11/688768

Inventors:

Pinaki Ray - Fremont CA, US
Greg Matian - Foster City CA, US
Aparna Srinivasan - San Jose CA, US
Pamela Lai - Campbell CA, US
David Rodbard - Potomac MD, US
Roger Levine - Redwood City CA, US
Andrea Burling - Santa Clara CA, US
Laura Robinson - Los Gatos CA, US
David Price - Pleasanton CA, US

International Classification:

A61B 5/00
G01N 33/48

US Classification:

705 3, 600300, 702 19

Abstract:

A diabetes management system or process is provided herein that may be used to analyze and recognize patterns for a large amount of blood glucose concentration measurements and other physiological parameters related to the glycemia of a patient. In particular, a communication medium is provided. The communication medium includes first, second, third, fourth and fifth display areas. The second through fifth display areas can be disposed in the first display area. The second display area has identification information of a patient. The third display area has a plurality of textual messages indicative of glycemic status of the patient. The fourth display area includes a chart indicative of a variability of the glucose concentration of the patient over a predetermined time period. Other messages can also be provided to ensure compliance of any prescribed diabetes regiments or to guide the patient in managing the patient's diabetes.